![](https://img.einnews.com/small/702637/neurofibromatosis-type-1-market.png)
Future Scope of Neurofibromatosis Type-1 Market Expected to Expand at a Steady 2024-2031 | AstraZeneca PLC
Neurofibromatosis type-1 is a rare disease condition characterized by changes in skin colour and growing of tumors in nerves of the skin along the body. BURLINGAME, CALIFORNIA , UNITED STATES, July 9, 2024 /EINPresswire.com/ -- …